这是一篇来自已证抗体库的有关人类 EGF的综述,是根据17篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合EGF 抗体。
EGF 同义词: HOMG4; URG; pro-epidermal growth factor; beta-urogastrone

艾博抗(上海)贸易有限公司
兔 多克隆
  • 免疫印迹; 人类; 图 1
艾博抗(上海)贸易有限公司 EGF抗体(Abcam, ab9695)被用于被用于免疫印迹在人类样品上 (图 1). Breast Cancer Res (2015) ncbi
伯乐(Bio-Rad)公司
兔 多克隆
  • 免疫组化-石蜡切片; 人类; 图 2a
伯乐(Bio-Rad)公司 EGF抗体(Abd Serotec, AHP767)被用于被用于免疫组化-石蜡切片在人类样品上 (图 2a). Oncotarget (2017) ncbi
LifeSpan Biosciences
山羊 多克隆
  • 免疫组化-石蜡切片; 兔; 图 3
LifeSpan Biosciences EGF抗体(LSBio, Ls-B11905)被用于被用于免疫组化-石蜡切片在兔样品上 (图 3). PLoS ONE (2016) ncbi
安迪生物R&D
山羊 多克隆
  • proximity ligation assay; 人类; 图 3C
安迪生物R&D EGF抗体(R&D, AF4289)被用于被用于proximity ligation assay在人类样品上 (图 3C). PLoS ONE (2016) ncbi
赛默飞世尔
小鼠 单克隆(4E11)
  • 免疫印迹; 小鼠; 1:1,000
赛默飞世尔 EGF抗体(生活技术, 4E11)被用于被用于免疫印迹在小鼠样品上浓度为1:1,000. J Biol Chem (2014) ncbi
赛信通(上海)生物试剂有限公司
兔 单克隆(C74B9)
  • 免疫印迹; 人类; 图 7f
赛信通(上海)生物试剂有限公司 EGF抗体(cell signalling, 2646)被用于被用于免疫印迹在人类样品上 (图 7f). Proc Natl Acad Sci U S A (2017) ncbi
兔 单克隆(C74B9)
  • 免疫印迹; 小鼠; 图 1f
赛信通(上海)生物试剂有限公司 EGF抗体(Cell Signaling, 2646)被用于被用于免疫印迹在小鼠样品上 (图 1f). Science (2017) ncbi
兔 单克隆(C74B9)
  • 免疫印迹; 人类; 1:1000; 图 3f
赛信通(上海)生物试剂有限公司 EGF抗体(Cell Signaling, 2646)被用于被用于免疫印迹在人类样品上浓度为1:1000 (图 3f). Exp Ther Med (2016) ncbi
兔 单克隆(C74B9)
  • 免疫印迹; 人类; 图 1a
赛信通(上海)生物试剂有限公司 EGF抗体(Cell Signaling, 2646)被用于被用于免疫印迹在人类样品上 (图 1a). J Proteomics (2017) ncbi
兔 单克隆(C74B9)
  • 免疫印迹; 小鼠; 图 4
赛信通(上海)生物试剂有限公司 EGF抗体(Cell Signaling, 2646)被用于被用于免疫印迹在小鼠样品上 (图 4). Front Oncol (2015) ncbi
兔 单克隆(C74B9)
  • 免疫组化-石蜡切片; 人类; 1:50; 图 4
  • 免疫印迹; 人类; 图 4
赛信通(上海)生物试剂有限公司 EGF抗体(Cell Signaling Tech, C74B9)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:50 (图 4) 和 被用于免疫印迹在人类样品上 (图 4). Oncotarget (2015) ncbi
兔 单克隆(C74B9)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 EGF抗体(Cell Signaling Technology, 2646)被用于被用于免疫印迹在人类样品上. J Diabetes (2016) ncbi
兔 单克隆(C74B9)
  • 免疫印迹; 仓鼠; 图 7a
赛信通(上海)生物试剂有限公司 EGF抗体(Cell Signaling, 2646)被用于被用于免疫印迹在仓鼠样品上 (图 7a). J Biol Chem (2015) ncbi
兔 单克隆(C74B9)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 EGF抗体(Cell Signaling, 2646)被用于被用于免疫印迹在小鼠样品上. PLoS ONE (2014) ncbi
兔 单克隆(C74B9)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 EGF抗体(Cell Signaling Technology, 2646)被用于被用于免疫印迹在人类样品上. J Cancer Res Clin Oncol (2015) ncbi
兔 单克隆(C74B9)
  • 免疫印迹; 人类; 图 1c
赛信通(上海)生物试剂有限公司 EGF抗体(Cell Signaling Technology, 2646)被用于被用于免疫印迹在人类样品上 (图 1c). Mol Cancer Ther (2014) ncbi
兔 单克隆(C74B9)
  • 免疫细胞化学; 人类; 图 3a
赛信通(上海)生物试剂有限公司 EGF抗体(Cell Signaling, C74B9)被用于被用于免疫细胞化学在人类样品上 (图 3a). Sci Signal (2012) ncbi
文章列表
  1. Liu S, Liu H, Johnston A, Hanna Addams S, Reynoso E, Xiang Y, et al. MLKL forms disulfide bond-dependent amyloid-like polymers to induce necroptosis. Proc Natl Acad Sci U S A. 2017;114:E7450-E7459 pubmed 出版商
  2. Bi P, Ramirez Martinez A, Li H, Cannavino J, McAnally J, Shelton J, et al. Control of muscle formation by the fusogenic micropeptide myomixer. Science. 2017;356:323-327 pubmed 出版商
  3. Khelwatty S, Essapen S, Bagwan I, Green M, Seddon A, Modjtahedi H. The impact of co-expression of wild-type EGFR and its ligands determined by immunohistochemistry for response to treatment with cetuximab in patients with metastatic colorectal cancer. Oncotarget. 2017;8:7666-7677 pubmed 出版商
  4. Jiang M, Qiu J, Zhang L, Lu D, Long M, Chen L, et al. Changes in tension regulates proliferation and migration of fibroblasts by remodeling expression of ECM proteins. Exp Ther Med. 2016;12:1542-1550 pubmed
  5. Grassi M, Palma C, Thomé C, Lanfredi G, Poersch A, Faça V. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control. J Proteomics. 2017;151:2-11 pubmed 出版商
  6. Li Y, Zhang J, Xu Y, Han Y, Jiang B, Huang L, et al. The Histopathological Investigation of Red and Blue Light Emitting Diode on Treating Skin Wounds in Japanese Big-Ear White Rabbit. PLoS ONE. 2016;11:e0157898 pubmed 出版商
  7. Thomas J, Chhuy Hy L, Andrykovich K, Moos M. SMOC Binds to Pro-EGF, but Does Not Induce Erk Phosphorylation via the EGFR. PLoS ONE. 2016;11:e0154294 pubmed 出版商
  8. Nikonova A, Deneka A, Eckman L, Kopp M, Hensley H, Egleston B, et al. Opposing Effects of Inhibitors of Aurora-A and EGFR in Autosomal-Dominant Polycystic Kidney Disease. Front Oncol. 2015;5:228 pubmed 出版商
  9. Donzelli S, Mori F, Bellissimo T, Sacconi A, Casini B, Frixa T, et al. Epigenetic silencing of miR-145-5p contributes to brain metastasis. Oncotarget. 2015;6:35183-201 pubmed 出版商
  10. Yoo J, Kim T, Kong S, Lee J, Choi W, Kim K, et al. Role of Mig-6 in hepatic glucose metabolism. J Diabetes. 2016;8:86-97 pubmed 出版商
  11. Liu Z, Leng E, Gunasekaran K, Pentony M, Shen M, Howard M, et al. A novel antibody engineering strategy for making monovalent bispecific heterodimeric IgG antibodies by electrostatic steering mechanism. J Biol Chem. 2015;290:7535-62 pubmed 出版商
  12. Blanchard Z, Paul B, Craft B, ElShamy W. BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers. Breast Cancer Res. 2015;17:5 pubmed 出版商
  13. Smithline Z, Nikonova A, Hensley H, Cai K, Egleston B, Proia D, et al. Inhibiting heat shock protein 90 (HSP90) limits the formation of liver cysts induced by conditional deletion of Pkd1 in mice. PLoS ONE. 2014;9:e114403 pubmed 出版商
  14. Shiba Fukushima K, Inoshita T, Hattori N, Imai Y. Lysine 63-linked polyubiquitination is dispensable for Parkin-mediated mitophagy. J Biol Chem. 2014;289:33131-6 pubmed 出版商
  15. Holland W, Chinn D, Lara P, Gandara D, Mack P. Effects of AKT inhibition on HGF-mediated erlotinib resistance in non-small cell lung cancer cell lines. J Cancer Res Clin Oncol. 2015;141:615-26 pubmed 出版商
  16. Zhang L, Castanaro C, Luan B, Yang K, Fan L, Fairhurst J, et al. ERBB3/HER2 signaling promotes resistance to EGFR blockade in head and neck and colorectal cancer models. Mol Cancer Ther. 2014;13:1345-55 pubmed 出版商
  17. Yamashita M, Chattopadhyay S, Fensterl V, Saikia P, Wetzel J, Sen G. Epidermal growth factor receptor is essential for Toll-like receptor 3 signaling. Sci Signal. 2012;5:ra50 pubmed 出版商